Gland Pharma Limited (NSE:GLAND)
1,487.50
+8.80 (0.60%)
Apr 24, 2025, 11:30 AM IST
Gland Pharma Revenue
Gland Pharma had revenue of 13.84B INR in the quarter ending December 31, 2024, a decrease of -10.43%. This brings the company's revenue in the last twelve months to 57.29B, up 16.63% year-over-year. In the fiscal year ending March 31, 2024, Gland Pharma had annual revenue of 56.65B with 56.29% growth.
Revenue (ttm)
57.29B
Revenue Growth
+16.63%
P/S Ratio
4.25
Revenue / Employee
13.59M
Employees
4,217
Market Cap
243.63B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |
Gland Pharma News
- 15 days ago - Indian pharma stocks tumble as Trump signals tariffs on drug imports - The Times of India
- 20 days ago - Gland Pharma shares drop over 5% as Trump hints at pharma tariffs - Business Upturn
- 21 days ago - Gland Pharma secures USFDA approval for Acetaminophen Injection - Business Upturn
- 21 days ago - Gland Pharma shares surge nearly 10% as Trump spares Indian pharma sector from 26% reciprocal tariff - Business Upturn
- 4 weeks ago - Pharma and hospital stocks in focus today: Alembic Pharma, Gland Pharma, Apollo Hospital, Fortis Healthcare, Dr Reddy’s [March 24, 2025] - Business Upturn
- 2 months ago - Gland Pharma receives three form 483 observations after US FDA inspection at JNPC facility - Business Upturn
- 2 months ago - Gland Pharma Ltd (NSE:GLAND) Q3 2025 Earnings Call Highlights: Strong Margins Amid Revenue ... - GuruFocus
- 2 months ago - Q3 2025 Gland Pharma Ltd Earnings Call Transcript - GuruFocus